CUE BIOPHARMA INC (CUE) Institutional Ownership and Insiders Activity

CUE BIOPHARMA INC (CUE) is widely held by institutional investors, with 48 firms reporting positions valued at approximately $52.16M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Bleichroeder Lp is the largest disclosed holder, reporting approximately $11.70M in CUE holdings in its latest filing.

Recent insider activity includes 36 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.